1. How did you find out you had KRAS-positive lung cancer?

2. What was the comprehensive biomarker testing experience like?

3. What has your treatment experience been for your KRAS-positive lung cancer?

4. What advice do you have for newly diagnosed lung cancer patients about biomarker testing?

Patient Video - How did you find out you had KRAS-positive lung cancer?

Chris shares his lung cancer diagnosis journey and talks about the significance of the comprehensive biomarker testing that revealed he has the KRAS G12C lung cancer mutation.

Click here to take our SURVEY
Your feedback is important to us! We will use your feedback to develop future areas of content about lung cancer which will help other patients, caregivers and families.

Section: Chris' Story

1. How did you find out you had KRAS-positive lung cancer?

2. What was the comprehensive biomarker testing experience like?

3. What has your treatment experience been for your KRAS-positive lung cancer?

4. What advice do you have for newly diagnosed lung cancer patients about biomarker testing?

Other Modules:

Understanding Non-Small Cell Lung Cancer (NSCLC)

Understanding Small Cell Lung Cancer (SCLC)

Screening for Lung Cancer

Lung Cancer Screening for Black Americans

Lung Cancer Screening for Native Americans

Diagnosis and Screening of Lung Cancer

Staging of Lung Cancer

Understanding Biomarker Testing in Non-Small Cell Lung Cancer

NGS and CGP for Lung Cancer

Treatment and Management of Lung Cancer

Immunotherapy for Lung Cancer

Targeted Therapy in Non-Small Cell Lung Cancer

Understanding Clinical Trials in Lung Cancer

Lung Cancer Clinical Trials and the US Black Community

Lung Cancer Clinical Trials and Native Americans

NSCLC Treatment When You Have an EGFR Mutation

NSCLC Treatment Options When You Have an EGFR Mutation

NSCLC Treatment When You Have a KRAS Mutation

NSCLC Treatment Options When You Have a KRAS Mutation

NSCLC Treatment for Less Common Mutations: ALK, BRAF, ROS1, HER2, MET

Immunotherapy for NSCLC with PD-1 and PD-L1 Biomarkers

Understanding Prehabilitation for Lung Cancer Surgery

Your Prehabilitation Plan for Lung Cancer Surgery

Patient Stories:

Mr. Satterfield's Story

Sharon’s Story

Terri's Story

Tricia's Story

This educational activity has been developed by A Breath of Hope Lung Foundation and Mechanisms in Medicine Inc.

This activity is supported by educational grants from AstraZeneca Pharmaceuticals, Bristol-Myers Squibb Foundation Inc., Bristol-Myers Squibb Grants and Giving, Foundation Medicine, Genentech, Jazz Pharmaceuticals, Merck Sharp & Dohme LLC, Neogenomics, Novartis, Pfizer, and Takeda Oncology.

This website is part of the Animated Patient^® series developed by Mechanisms in Medicine Inc., to provide highly visual formats of learning for patients to improve their understanding, make informed shared decisions, and partner with their healthcare professionals for optimal outcomes.